VIVIAN TURNER: Open Payments
NPI 1164670592 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,040 in 45 payments from 11 companies in 2025. Trend: 2023 $586 · 2024 $1,604 · 2025 $1,040
Food & beverage: $940Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $357 |
| GENZYME CORPORATION | 6 | $186 |
| ABBVIE INC. | 15 | $175 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $70 |
| Galderma Laboratories, L.P. | 3 | $66 |
| Lilly USA, LLC | 2 | $50 |
| Amgen Inc. | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| LEO Pharma Inc. | 1 | $24 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, ILUMYA, NEMLUVIO, TALTZ, Otezla, Sotyktu.
Industry payments across CA — which companies pay providers there.
